Oak Therapeutics and KU Medical Center cooperate on NIH-funded research

Together with Kansas University Medical Center, Oak Therapeutics will contribute to improving infant antiretroviral therapy (ART). One of the aims of the joint project 1R21HD105534-01 titled "Assessing caregiver and child preferences for the development of novel pediatric antiretroviral therapy”, funded by the National Institutes of Health (NIH) is to design a patient-centered approach to the development of an Oral Dissolvable Strip (ODS) for the treatment of HIV in infants and children.

Featured Posts
Recent Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square